Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review

Preventive transhepatic tract embolisation (PTTE) after percutaneous biliary intervention (PBI) may reduce adverse events. The aim of this systematic review was to analyse feasibility, safety, and efficacy of PTTE with different embolic agents. A systematic literature research was performed accordin...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel Schmitz, De-Hua Chang, Jochen Rudi, Svetlana Hetjens, Matthias P. A. Ebert
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2020/8849284
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850174986185080832
author Daniel Schmitz
De-Hua Chang
Jochen Rudi
Svetlana Hetjens
Matthias P. A. Ebert
author_facet Daniel Schmitz
De-Hua Chang
Jochen Rudi
Svetlana Hetjens
Matthias P. A. Ebert
author_sort Daniel Schmitz
collection DOAJ
description Preventive transhepatic tract embolisation (PTTE) after percutaneous biliary intervention (PBI) may reduce adverse events. The aim of this systematic review was to analyse feasibility, safety, and efficacy of PTTE with different embolic agents. A systematic literature research was performed according to the PRISMA guidelines. The identified studies were analysed concerning study quality, number of cases, indication, embolic agent, embolisation technique, success, and embolisation-related adverse events. Out of 62 identified records, 7 studies of mainly moderate study quality published through 2019 were included for further analysis. Cyanoacrylate (n = 4), gelatin sponge (n = 2), and coils (n = 1) were used as embolic agents in a total number of 314 patients. Technical success was 96–100%. Embolisation-related adverse events (glue migration, pain) occurred in 10/314 (3.2%) patients. Reduction of PBI-related pain was approved by one controlled study; haemorrhage events were reduced but not clearly significant. Overall, biliary leak, transhepatic bleeding, and PBI-related pain occurred in 7/201 (3.5%), 1/293 (0.3%), and 17/46 (36.9%) documented patients after PTTE. Adverse events which likely could not have been prevented by PTTE occurred in 23/180 (12.8%) patients. Embolic agents were not compared. In conclusion, PTTE is feasible and safe. It is effective concerning the prevention of PBI-related pain, and it may be effective concerning haemorrhage. Prevention of biliary leak is not proven. It remains unclear which embolic agent should be preferred. A prospective randomised trial including all preventable adverse events is lacking.
format Article
id doaj-art-d6e5d18443ad4cfba3d9990f1ce182c8
institution OA Journals
issn 2291-2797
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-d6e5d18443ad4cfba3d9990f1ce182c82025-08-20T02:19:33ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27972020-01-01202010.1155/2020/88492848849284Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic ReviewDaniel Schmitz0De-Hua Chang1Jochen Rudi2Svetlana Hetjens3Matthias P. A. Ebert4Department of Gastroenterology, Oncology and DiabetologyDepartment of Diagnostic and Interventional RadiologyDepartment of Gastroenterology, Oncology and DiabetologyDepartment of Medical StatisticsDepartment of Medicine IIPreventive transhepatic tract embolisation (PTTE) after percutaneous biliary intervention (PBI) may reduce adverse events. The aim of this systematic review was to analyse feasibility, safety, and efficacy of PTTE with different embolic agents. A systematic literature research was performed according to the PRISMA guidelines. The identified studies were analysed concerning study quality, number of cases, indication, embolic agent, embolisation technique, success, and embolisation-related adverse events. Out of 62 identified records, 7 studies of mainly moderate study quality published through 2019 were included for further analysis. Cyanoacrylate (n = 4), gelatin sponge (n = 2), and coils (n = 1) were used as embolic agents in a total number of 314 patients. Technical success was 96–100%. Embolisation-related adverse events (glue migration, pain) occurred in 10/314 (3.2%) patients. Reduction of PBI-related pain was approved by one controlled study; haemorrhage events were reduced but not clearly significant. Overall, biliary leak, transhepatic bleeding, and PBI-related pain occurred in 7/201 (3.5%), 1/293 (0.3%), and 17/46 (36.9%) documented patients after PTTE. Adverse events which likely could not have been prevented by PTTE occurred in 23/180 (12.8%) patients. Embolic agents were not compared. In conclusion, PTTE is feasible and safe. It is effective concerning the prevention of PBI-related pain, and it may be effective concerning haemorrhage. Prevention of biliary leak is not proven. It remains unclear which embolic agent should be preferred. A prospective randomised trial including all preventable adverse events is lacking.http://dx.doi.org/10.1155/2020/8849284
spellingShingle Daniel Schmitz
De-Hua Chang
Jochen Rudi
Svetlana Hetjens
Matthias P. A. Ebert
Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review
Canadian Journal of Gastroenterology and Hepatology
title Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review
title_full Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review
title_fullStr Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review
title_full_unstemmed Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review
title_short Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review
title_sort preventive transhepatic tract embolisation after percutaneous biliary interventions a systematic review
url http://dx.doi.org/10.1155/2020/8849284
work_keys_str_mv AT danielschmitz preventivetranshepatictractembolisationafterpercutaneousbiliaryinterventionsasystematicreview
AT dehuachang preventivetranshepatictractembolisationafterpercutaneousbiliaryinterventionsasystematicreview
AT jochenrudi preventivetranshepatictractembolisationafterpercutaneousbiliaryinterventionsasystematicreview
AT svetlanahetjens preventivetranshepatictractembolisationafterpercutaneousbiliaryinterventionsasystematicreview
AT matthiaspaebert preventivetranshepatictractembolisationafterpercutaneousbiliaryinterventionsasystematicreview